Literature DB >> 28106065

Neuro-oncology in 2016: Advances in brain tumour classification and therapy.

Matthias Preusser1, Christine Marosi1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28106065     DOI： 10.1038/nrneurol.2017.3

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  8 in total

1.  Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma.

Authors:  Jan C Buckner; Edward G Shaw; Stephanie L Pugh; Arnab Chakravarti; Mark R Gilbert; Geoffrey R Barger; Stephen Coons; Peter Ricci; Dennis Bullard; Paul D Brown; Keith Stelzer; David Brachman; John H Suh; Christopher J Schultz; Jean-Paul Bahary; Barbara J Fisher; Harold Kim; Albert D Murtha; Erica H Bell; Minhee Won; Minesh P Mehta; Walter J Curran
Journal:  N Engl J Med       Date:  2016-04-07       Impact factor: 91.245

Review 2.  Chemotherapy for low-grade glioma: when, for whom, which regimen?

Authors:  Martin J van den Bent
Journal:  Curr Opin Neurol       Date:  2015-12       Impact factor: 5.710

Review 3.  Management of diffusely infiltrating glioma in the elderly.

Authors:  Hans-Georg Wirsching; Caroline Happold; Patrick Roth; Michael Weller
Journal:  Curr Opin Oncol       Date:  2015-11       Impact factor: 3.645

Review 4.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

Authors:  David N Louis; Arie Perry; Guido Reifenberger; Andreas von Deimling; Dominique Figarella-Branger; Webster K Cavenee; Hiroko Ohgaki; Otmar D Wiestler; Paul Kleihues; David W Ellison
Journal:  Acta Neuropathol       Date:  2016-05-09       Impact factor: 17.088

5.  Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.

Authors:  Jaap C Reijneveld; Martin J B Taphoorn; Corneel Coens; Jacoline E C Bromberg; Warren P Mason; Khê Hoang-Xuan; Gail Ryan; Mohamed Ben Hassel; Roelien H Enting; Alba A Brandes; Antje Wick; Olivier Chinot; Michele Reni; Guy Kantor; Brian Thiessen; Martin Klein; Eugenie Verger; Christian Borchers; Peter Hau; Michael Back; Anja Smits; Vassilis Golfinopoulos; Thierry Gorlia; Andrew Bottomley; Roger Stupp; Brigitta G Baumert
Journal:  Lancet Oncol       Date:  2016-09-27       Impact factor: 41.316

Review 6.  Prospects of immune checkpoint modulators in the treatment of glioblastoma.

Authors:  Matthias Preusser; Michael Lim; David A Hafler; David A Reardon; John H Sampson
Journal:  Nat Rev Neurol       Date:  2015-08-11       Impact factor: 42.937

7.  ABT-414, an Antibody-Drug Conjugate Targeting a Tumor-Selective EGFR Epitope.

Authors:  Andrew C Phillips; Erwin R Boghaert; Kedar S Vaidya; Michael J Mitten; Suzanne Norvell; Hugh D Falls; Peter J DeVries; Dong Cheng; Jonathan A Meulbroek; Fritz G Buchanan; Laura M McKay; Neal C Goodwin; Edward B Reilly
Journal:  Mol Cancer Ther       Date:  2016-02-04       Impact factor: 6.261

8.  Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.

Authors:  Brigitta G Baumert; Monika E Hegi; Martin J van den Bent; Andreas von Deimling; Thierry Gorlia; Khê Hoang-Xuan; Alba A Brandes; Guy Kantor; Martin J B Taphoorn; Mohamed Ben Hassel; Christian Hartmann; Gail Ryan; David Capper; Johan M Kros; Sebastian Kurscheid; Wolfgang Wick; Roelien Enting; Michele Reni; Brian Thiessen; Frederic Dhermain; Jacoline E Bromberg; Loic Feuvret; Jaap C Reijneveld; Olivier Chinot; Johanna M M Gijtenbeek; John P Rossiter; Nicolas Dif; Carmen Balana; Jose Bravo-Marques; Paul M Clement; Christine Marosi; Tzahala Tzuk-Shina; Robert A Nordal; Jeremy Rees; Denis Lacombe; Warren P Mason; Roger Stupp
Journal:  Lancet Oncol       Date:  2016-09-27       Impact factor: 54.433
  8 in total
  4 in total

Review 1.  ctDNA-Based Liquid Biopsy of Cerebrospinal Fluid in Brain Cancer.

Authors:  Laura Escudero; Francisco Martínez-Ricarte; Joan Seoane
Journal:  Cancers (Basel)       Date:  2021-04-21       Impact factor: 6.639

2.  Global, regional, and national burden of brain and other CNS cancer, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Authors: 
Journal:  Lancet Neurol       Date:  2019-02-21       Impact factor: 44.182

Review 3.  The Roles of 2-Hydroxyglutarate.

Authors:  Xin Du; Hai Hu
Journal:  Front Cell Dev Biol       Date:  2021-03-26

Review 4.  Epigenetic Regulation of Telomere Maintenance for Therapeutic Interventions in Gliomas.

Authors:  Elisabeth Naderlinger; Klaus Holzmann
Journal:  Genes (Basel)       Date:  2017-05-17       Impact factor: 4.096
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.